Equine viral arteritis (EVA) is an acute, contagious, viral disease of equids caused by equine arteritis virus (EAV).
Typical cases are characterized by fever,
depression, anorexia, leukopenia, dependent edema (especially of the lower hind extremities, scrotum, and prepuce in the stallion), Etiology
equine arteritis virus (EAV).
genus Arterivirus, family Arteriviridae Transmission EVA is primarily a respiratory disease. Particles from acutely infected horses’ nasal discharges are inhaled, and this close contact facilitates the spread of the virus.
can also be transmitted venereally
Pathogenesis After respiratory exposure, EAV invades the upper and lower respiratory tract and multiplies in nasopharyngeal epithelium and tonsillar tissue and in bronchial and alveolar macrophages. Infected cells of the monocytic and T lymphocytes transport the virus to the regional lymph nodes, where it undergoes a further cycle of replication before being released into the bloodstream. By 6–8 days, the virus localizes in the vascular endothelium and myocytes of the smaller blood vessels, especially the arterioles, and causes a vasculitis.
Itcan also be found in the epithelium of
certain tissue adrenals, seminiferous tubules, thyroid, and liver. . Theselesions give rise to edema and hemorrhage,
Based on experimental infection of pregnant
mares cause , abortion is believed to result from a myometritis that gives rise to impairment of the placental circulation and death of the fetus Clinical signs Exposure to EAV may result in clinical or asymptomatic infection, depending on the relative pathogenicity of the virus strain involved, viral dose, age and physical condition of the animal
incubation period of 3–14 days
fever lasting 2–9 days, depression, anorexia, limb edema (especially of the lower hindlimbs), and scrotum and prepuce.
Less frequently signs include conjunctivitis,
lacrimation and photophobia, rhinitis and nasal discharge, edema of the ventral body wall (including the mammary glands of mares),
stiffness of gait, dyspnea, petechiation of mucous membranes, diarrhea, icterus, and ataxia. Stallions with EVA may undergo a period of short-term subfertility
Abortion in pregnant mare
Diagnosis Virus isolation can be attempted from swabs of the nose, throat, or eyes; semen, placentas, or fetal tissue; and blood samples PCR (ELISA) Treatment and control Treatment While there is no specific treatment for EVA
Antipyretic and Antibiotics, which may
decrease the risk of secondary bacterial infection Only one commercial vaccine, a modified-live virus product.
Arterial Events, Venous Thromboembolism, Thrombocytopenia, and Bleeding After Vaccination With Oxford-Astrazeneca Chadox1-S in Denmark and Norway: Population Based Cohort Study